The last decade has witnessed conflicting results regarding topo IIa status in prediction of anthracycline benefit. Evidence to date cannot support clinical application of TOP2A for women with early breast cancer
Re-searching anthracycline therapy / Oakman C; Moretti E; Di Leo A. - In: BREAST CANCER RESEARCH AND TREATMENT. - ISSN 0167-6806. - ELETTRONICO. - (2010), pp. 171-175.
Re-searching anthracycline therapy
MORETTI, ERICA;
2010
Abstract
The last decade has witnessed conflicting results regarding topo IIa status in prediction of anthracycline benefit. Evidence to date cannot support clinical application of TOP2A for women with early breast cancer
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
